Eusol Biotech Co.,Ltd. (TPEX:6652)
1.960
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Eusol Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 191.51 | 248.65 | 213.69 | 144.66 | 248.08 |
Short-Term Investments | 109.31 | 95.51 | 165.6 | 250.6 | 30 |
Cash & Short-Term Investments | 300.82 | 344.16 | 379.29 | 395.26 | 278.08 |
Cash Growth | -12.59% | -9.26% | -4.04% | 42.14% | 281.83% |
Accounts Receivable | 0.17 | - | - | - | - |
Other Receivables | 23.81 | 28.99 | 24.56 | 18.18 | 18.42 |
Receivables | 23.97 | 28.99 | 24.56 | 18.18 | 18.42 |
Inventory | 3.09 | 1.01 | - | - | - |
Prepaid Expenses | 0.31 | 0.25 | 0.22 | 6.02 | 8.49 |
Other Current Assets | - | - | - | 0.01 | 0.01 |
Total Current Assets | 328.19 | 374.41 | 404.07 | 419.46 | 305 |
Property, Plant & Equipment | 14.03 | 2.99 | 5.74 | 10.71 | 78.01 |
Long-Term Investments | 6.42 | - | - | 10.1 | 9.91 |
Goodwill | - | - | - | 0.08 | 0.08 |
Other Intangible Assets | 0.08 | 0.08 | 0.05 | 0.06 | 60.88 |
Other Long-Term Assets | 0.69 | 0.44 | 0.4 | 0.4 | 1.03 |
Total Assets | 349.41 | 377.91 | 410.26 | 440.81 | 454.91 |
Accounts Payable | - | 0.32 | 0.39 | - | 0.51 |
Accrued Expenses | 6.9 | 4.74 | 4.18 | 6.05 | 13.93 |
Current Portion of Leases | 2.27 | 1.61 | 2.36 | 2.3 | 3.72 |
Current Income Taxes Payable | - | - | - | 6.02 | - |
Other Current Liabilities | 1.22 | 0.81 | 0.74 | 0.65 | 1.96 |
Total Current Liabilities | 10.39 | 7.48 | 7.67 | 15.03 | 20.13 |
Long-Term Leases | 9 | - | 1.61 | 3.97 | 0.75 |
Total Liabilities | 19.39 | 7.48 | 9.28 | 18.99 | 20.88 |
Common Stock | 1,370 | 1,370 | 1,370 | 1,370 | 1,370 |
Additional Paid-In Capital | 551.51 | 551.51 | 551.51 | 551.51 | 551.51 |
Retained Earnings | -1,591 | -1,551 | -1,521 | -1,493 | -1,474 |
Comprehensive Income & Other | - | - | - | -7.11 | -13.21 |
Shareholders' Equity | 330.02 | 370.43 | 400.98 | 421.82 | 434.03 |
Total Liabilities & Equity | 349.41 | 377.91 | 410.26 | 440.81 | 454.91 |
Total Debt | 11.27 | 1.61 | 3.97 | 6.27 | 4.47 |
Net Cash (Debt) | 289.55 | 342.55 | 375.33 | 388.99 | 273.61 |
Net Cash Growth | -15.47% | -8.73% | -3.51% | 42.17% | 320.82% |
Net Cash Per Share | 2.11 | 2.50 | 2.74 | 2.84 | 2.04 |
Filing Date Shares Outstanding | 137 | 137 | 137 | 137 | 137 |
Total Common Shares Outstanding | 137 | 137 | 137 | 137 | 137 |
Working Capital | 317.8 | 366.93 | 396.4 | 404.43 | 284.88 |
Book Value Per Share | 2.41 | 2.70 | 2.93 | 3.08 | 3.17 |
Tangible Book Value | 329.94 | 370.36 | 400.94 | 421.67 | 373.08 |
Tangible Book Value Per Share | 2.41 | 2.70 | 2.93 | 3.08 | 2.72 |
Land | - | - | - | - | 12.1 |
Buildings | - | - | - | - | 55.74 |
Machinery | 15.01 | 15.36 | 16.62 | 20.15 | 92.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.